☆ 4.7 Meeting Abstract

Efficacy and Safety of Crisaborole Topical Ointment, 2%, a Novel, Nonsteroidal, Topical, Anti-Inflammatory, Phosphodiesterase Inhibitor in 2 Phase 3 Studies in Children and Adults with Mild-to-Moderate Atopic Dermatitis

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Get Full Text
Add to Collection

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 137, Issue 2, Pages AB397-AB397

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2015.12.1230

Keywords

-

Categories

Allergy Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.